InsidersTradesSigma
Track the 프로티아 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 프로티아 has logged 6 insider filings. Market capitalisation: €62bn. The latest transaction was disclosed on 10 March 2026 (Purchase). Among the most active insiders: 손순진. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
Protia 是一家在 XKRX 市场上市的医疗保健和制药公司。它致力于开发创新解决方案以改善患者健康。